Oxytetracycline is formulated to treat active infections caused by Chlamydia (such as the chest infection psittacosis, the eye infection trachoma, and the genital infection urethritis) and critical infections caused by Mycoplasma organisms (such as pneumonia). Its hydrochloride variation is highly effective and widely used. Oxytetracycline hydrochloride presents as a yellow crystalline powder, is odorless and bitter; it easily absorbs moisture, darkens gradually when exposed to sunlight, and can degrade in alkaline environments.

This substance is exceptionally valuable in targeted treatments for nonspecific urethritis, Lyme disease, brucellosis, cholera, typhus, tularaemia, and infections caused by Chlamydia, Mycoplasma, and Rickettsia. Doxycycline serves as a preferred alternative to oxytetracycline for multiple indications due to its refined pharmacological attributes.

Our partner manufacturer was established in 2002. It operates as a large-scale, GMP-certified veterinary drug enterprise, integrating comprehensive R&D, advanced production, and international sales of veterinary APIs, high-efficacy preparations, premixed feeds, and essential feed additives. Operating with a high-caliber Provincial Technical Center, the developer maintains an innovative R&D architecture dedicated to next-generation veterinary medication, supported by over 65 dedicated technical professionals.

The enterprise runs two state-of-the-art production bases, with the main headquarters base covering a vast area of 78,706 m². The manufacturing capacity spans 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, and Oxytetracycline Hydrochloride, alongside 12 streamlined preparation production lines covering injections, oral solutions, soluble powders, premixes, boluses, environmental sanitizers, and advanced disinfectants. Custom API solutions, over 100 own-label formulations, and expert OEM & ODM services are continuously offered to global partners.

Outstanding emphasis is placed on highly structured EHS (Environment, Health & Safety) systems, which has earned full ISO14001 and OHSAS18001 certifications. Strategic inventory and supply chain resilience allow the enterprise to guarantee a steady, uninterrupted product supply to international buyers.

A comprehensive quality control framework governs all processes, validated by ISO9001 certificates, state GMP certificates, Australian APVMA GMP clearances, Ethiopian GMP validations, Ivermectin CEP certificates, and successful US FDA inspections. A professional registration, sales, and technical support network ensures seamless international partnership, exporting to over 60 countries and regions spanning Europe, South America, the Middle East, Africa, and Asia.